Hong Kong (HSI) Growth Pharmaceuticals & Biotech Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Aug 09, 2025

Discover Hong Kong Pharmaceuticals & Biotech Growth Stocks that are on the HSI. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

113 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
1952 Everest Medicines	HK$71.30	14.8%	259.4%	HK$25.0b	HK$55.29	PS32.4x	E108.3%	n/a
6185 CanSino Biologics	HK$49.46	13.1%	160.3%	HK$17.0b	HK$43.15	PS12.9x	E107.5%	0%
1477 Ocumension Therapeutics	HK$10.57	12.2%	44.8%	HK$8.6b	HK$8.73	PS18.9x	E101.4%	n/a
2171 CARsgen Therapeutics Holdings	HK$20.02	2.2%	408.1%	HK$10.6b	HK$22.08	PS247x	E96.1%	n/a
2228 XtalPi Holdings	HK$7.11	24.7%	23.0%	HK$28.6b	HK$8.69	PS98.1x	E90.8%	n/a
9969 InnoCare Pharma	HK$17.42	-0.9%	283.7%	HK$34.4b	HK$14.04	PS22.9x	E79.5%	n/a
2616 CStone Pharmaceuticals	HK$7.00	3.9%	460.0%	HK$10.2b	HK$6.56	PS22.9x	E68.7%	n/a
9995 RemeGen	HK$64.70	10.3%	355.6%	HK$37.3b	HK$43.39	PS17.2x	E66.3%	n/a
1548 Genscript Biotech	HK$16.95	2.1%	27.1%	HK$37.0b	HK$21.61	PS7.9x	E65.8%	0%
2487 Cutia Therapeutics	HK$8.55	0.4%	12.5%	HK$2.7b	HK$10.90	PS8.9x	E65.0%	n/a
2410 TYK Medicines	HK$17.95	3.0%	n/a	HK$6.8b	HK$31.59	PS58351.4x	E63.9%	n/a
6855 Ascentage Pharma Group International	HK$82.55	14.7%	188.6%	HK$30.7b	HK$75.50	PS28.6x	E63.1%	n/a
2480 Beijing Luzhu Biotechnology	HK$23.30	-0.9%	4.5%	HK$4.6b	HK$30.89	PB5x	E59.4%	n/a
6996 Antengene	HK$5.10	6.7%	764.4%	HK$3.5b	HK$2.61	PS34.5x	E58.5%	n/a
1521 Frontage Holdings	HK$1.58	5.3%	116.4%	HK$3.2b	HK$1.10	PE514.9x	E51.9%	n/a
9606 Duality Biotherapeutics	HK$365.20	12.4%	n/a	HK$32.2b	HK$320.91	PS15.2x	E49.8%	n/a
1877 Shanghai Junshi Biosciences	HK$29.16	18.8%	150.1%	HK$42.3b	HK$21.12	PS13.2x	E47.1%	n/a
9926 Akeso	HK$160.40	2.6%	266.2%	HK$144.0b	HK$122.34	PS62x	E41.2%	n/a
1801 Innovent Biologics	HK$91.25	-1.9%	119.1%	HK$156.3b	HK$86.36	PS15.2x	E38.4%	n/a
6990 Sichuan Kelun-Biotech Biopharmaceutical	HK$403.00	-0.5%	158.3%	HK$92.1b	HK$330.26	PS43.6x	E36.5%	n/a
2142 HBM Holdings	HK$10.40	15.3%	732.0%	HK$8.2b	HK$12.07	PE378.3x	E32.8%	n/a
2162 Keymed Biosciences	HK$68.15	10.7%	102.5%	HK$20.1b	HK$63.71	PS42.9x	E31.4%	n/a
1873 Viva Biotech Holdings	HK$1.85	15.6%	270.0%	HK$3.9b	HK$3.20	PE21.3x	E26.1%	0%
2268 WuXi XDC Cayman	HK$56.05	1.0%	199.7%	HK$67.5b	HK$54.15	PE57.8x	E24.6%	n/a

Page 1 of 5